Drug Approval | May 27, 2022
USFDA approves Omeprazole capsules to prevent heartburn
Perrigo expects to launch Omeprazole Minis later this year
Perrigo expects to launch Omeprazole Minis later this year
The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets
Ulcerative colitis is a chronic, immune-mediated inflammatory bowel disease that can lead to substantial burden and often disability among patients
Dupixent is the first and only medicine indicated to treat eosinophilic esophagitis in the United States; approval granted more than two months ahead of USFDA’s Priority Review action date
If approved, ABBV-951 will offer patients the first continuous subcutaneous delivery of carbidopa/levodopa prodrugs
Multiples is the first private equity (PE) investor in the company
Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose
Company's net income rose by 57.5 percent to 3.291 billion euros in Q1
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
The facility is among 12 centres established worldwide, and the first in Asia
Subscribe To Our Newsletter & Stay Updated
